Informatie:
Fout:
ID
31635
Beschrijving
ARMOR1: Study of TOK-001 to Treat Castration Resistant Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00959959
Link
https://clinicaltrials.gov/show/NCT00959959
Trefwoorden
Versies (1)
- 14-09-18 14-09-18 -
Houder van rechten
See clinicaltrials.gov
Geüploaded op
14 september 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Prostate Cancer NCT00959959
Eligibility Prostate Cancer NCT00959959
- StudyEvent: Eligibility
Similar models
Eligibility Prostate Cancer NCT00959959
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Informed Consent
Item
signed informed consent form
boolean
C0021430 (UMLS CUI [1])
Prostate carcinoma
Item
confirmed cancer of the prostate
boolean
C0600139 (UMLS CUI [1])
Disease Progression | Androgen ablation Resistant
Item
progressing disease in spite of androgen ablation therapy
boolean
C0242656 (UMLS CUI [1])
C1515985 (UMLS CUI [2,1])
C0332325 (UMLS CUI [2,2])
C1515985 (UMLS CUI [2,1])
C0332325 (UMLS CUI [2,2])
Able to swallow capsule multiple
Item
able to swallow multiple capsules
boolean
C2712086 (UMLS CUI [1,1])
C0006935 (UMLS CUI [1,2])
C0439064 (UMLS CUI [1,3])
C0006935 (UMLS CUI [1,2])
C0439064 (UMLS CUI [1,3])
Study Subject Participation Status
Item
participation in another clinical trial < 4 weeks prior to enrollment
boolean
C2348568 (UMLS CUI [1])
Neoplasm Metastasis
Item
metastatic disease with one or more of the following:
boolean
C0027627 (UMLS CUI [1])
Liver Involvement
Item
liver involvement
boolean
C0023884 (UMLS CUI [1,1])
C1314939 (UMLS CUI [1,2])
C1314939 (UMLS CUI [1,2])
Bone pain Associated with Neoplasm Metastasis
Item
bone pain associated with confirmed evidence of metastases
boolean
C0151825 (UMLS CUI [1,1])
C0332281 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,3])
C0332281 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,3])
Involvement Visceral Extrahepatic
Item
non-hepatic visceral involvement
boolean
C1314939 (UMLS CUI [1,1])
C0442045 (UMLS CUI [1,2])
C1517058 (UMLS CUI [1,3])
C0442045 (UMLS CUI [1,2])
C1517058 (UMLS CUI [1,3])
Pharmaceutical Preparations Specified
Item
the following medications:
boolean
C0013227 (UMLS CUI [1,1])
C0205369 (UMLS CUI [1,2])
C0205369 (UMLS CUI [1,2])
MDV 3100 | abiraterone | Provenge | TAK-700
Item
prior treatment with mdv3100, abiraterone, provenge or tak700
boolean
C2348174 (UMLS CUI [1])
C0754011 (UMLS CUI [2])
C1135133 (UMLS CUI [3])
C3467983 (UMLS CUI [4])
C0754011 (UMLS CUI [2])
C1135133 (UMLS CUI [3])
C3467983 (UMLS CUI [4])
Ketoconazole
Item
prior treatment with ketoconazole
boolean
C0022625 (UMLS CUI [1])
Prior Chemotherapy
Item
prior treatment with chemotherapy
boolean
C1514457 (UMLS CUI [1])
Prior radiation therapy
Item
prior radiation therapy completed ≤ 4 weeks prior to enrollment
boolean
C0279134 (UMLS CUI [1])
Medical condition Specified
Item
the following medical conditions:
boolean
C3843040 (UMLS CUI [1,1])
C0205369 (UMLS CUI [1,2])
C0205369 (UMLS CUI [1,2])
Angina Pectoris
Item
active angina pectoris
boolean
C0002962 (UMLS CUI [1])
Hepatitis B | Hepatitis C
Item
history of hepatitis b or hepatitis c
boolean
C0019163 (UMLS CUI [1])
C0019196 (UMLS CUI [2])
C0019196 (UMLS CUI [2])
HIV Infection
Item
known hiv infection
boolean
C0019693 (UMLS CUI [1])
Hypertensive disease
Item
ongoing hypertension
boolean
C0020538 (UMLS CUI [1])
Eligibility Criteria Additional
Item
note: there are additional inclusion and exclusion criteria. the clinical site center will determine if you are eligible. if you are not eligible for the trial, site staff will detail the reasons to you.
boolean
C1516637 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])
C1524062 (UMLS CUI [1,2])